Erik Reynolds is the Senior Vice President of Corporate Development for Global Medical Response, joining the
company in 2020. He has an extensive background in corporate-growth strategy and execution, and brings to the company a deep expertise in mergers and acquisitions, including joint ventures, divestitures, international transactions and strategic partnerships, with a focus on healthcare and life sciences.
Reynold’s vision for smart, strategic and organic corporate expansion is fueled by his passion for overseein
...Read More
Erik Reynolds is the Senior Vice President of Corporate Development for Global Medical Response, joining the
company in 2020. He has an extensive background in corporate-growth strategy and execution, and brings to the company a deep expertise in mergers and acquisitions, including joint ventures, divestitures, international transactions and strategic partnerships, with a focus on healthcare and life sciences.
Reynold’s vision for smart, strategic and organic corporate expansion is fueled by his passion for overseeing complex transactions that maximize enterprise value. His purpose-driven approach to dealmaking propels growth and purposeful diversification by thoroughly sourcing, analyzing, valuing and executing high-impact opportunities.
Before joining Global Medical Response, Reynolds was a Partner in Ernst and Young’s Strategy and Transactions Group where he supported healthcarefocused private equity investments and helped
reshape integrated health systems, academic medical centers, and physician practices, among other
healthcare ventures. Over his more than 20-year career, he has been a driving force behind more than
150 buy- and sell-side transactions with enterprise values ranging from $1 million to $10 billion.
Reynolds holds a Master of Science in Accountancy from the University of Virginia and a Bachelor of
Science in International Finance from Brigham Young University.
Read Less